We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Launched in January 2024, IRP aims to further help bring life-saving new medicines to UK patients without delay
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Information on depleted uranium (DU) including what it is, its uses, health effects and protection from exposure.
Projects granted during 2016 that have a primary purpose of translational and applied research - human cancer.
Projects granted during 2014 that have a primary purpose of translational and applied research: human cancer.
Projects granted during 2015 that have a primary purpose of basic research: musculoskeletal system.
Projects granted during 2015 that have a primary purpose of basic research: oncology.
Projects granted during 2015 that have a primary purpose of translational and applied research: projects on human cancer.
Overview of the UK's cancer research infrastructure and the advantages of investing in the UK's life science sector to develop new treatments.
SaBTO advice and recommendations on the risk of cancer being transmitted by an organ transplant, following a review of the evidence.
Projects granted during 2015 that have a primary purpose of basic research: immune system.
This is the council’s note about cancers of the larynx or ovary and work with asbestos.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).